涩里番

Dr. Cheng obtained his medical degree from 涩里番, and then subsequently completed his residency in internal medicine at the University of British Columbia. He then returned to 涩里番 to complete a combined fellowship in infectious diseases and medical microbiology. Afterwards, he completed a postdoctoral fellowship at the Harvard Medical School-affiliated Brigham and Women's Hospital and Dana-Farber Cancer Institute under the mentorship of Francisco Marty and Jerry Ritz before establishing his clinical research program at the 涩里番 Health Centre. His research program is funded by research operating grants from the US National Institutes of Health, the Canadian Institutes for Health Research, and the Australian National Health and Medical Research Council.

His research focuses on patients with potentially lethal infections, including those with severe manifestations of sepsis, bloodstream infections, and opportunistic infections in immunocompromised hosts. His program focuses on improving morbidity and mortality in these conditions by discovering original treatment strategies through avant-garde clinical trials. He also develops novel diagnostic assays to improve outcomes in these patients, such as using plasma cell-free DNA to monitor the host-response to infection and optimize treatment decisions.